Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Comput Intell Neurosci ; 2022: 7218113, 2022.
Article in English | MEDLINE | ID: mdl-35880061

ABSTRACT

Internet of Medical Thing (IoMT) is the most emerging era of the Internet of Thing (IoT), which is exponentially gaining researchers' attention with every passing day because of its wide applicability in Smart Healthcare systems (SHS). Because of the current pandemic situation, it is highly risky for an individual to visit the doctor for every small problem. Hence, using IoMT devices, we can easily monitor our day-to-day health records, and thereby initial precautions can be taken on our own. IoMT is playing a crucial role within the healthcare industry to increase the accuracy, reliability, and productivity of electronic devices. This research work provides an overview of IoMT with emphasis on various enabling techniques used in smart healthcare systems (SHS), such as radio frequency identification (RFID), artificial intelligence (AI), and blockchain. We are providing a comparative analysis of various IoMT architectures proposed by several researchers. Also, we have defined various health domains of IoMT, including the analysis of different sensors with their application environment, merits, and demerits. In addition, we have figured out key protocol design challenges, which are to be considered during the implementation of an IoMT network-based smart healthcare system. Considering these challenges, we prepared a comparative study for different data collection techniques that can be used to maintain the accuracy of collected data. In addition, this research work also provides a comprehensive study for maintaining the energy efficiency of an AI-based IoMT framework based on various parameters, such as the amount of energy consumed, packet delivery ratio, battery lifetime, quality of service, power drain, network throughput, delay, and transmission rate. Finally, we have provided different correlation equations for finding the accuracy and efficiency within the IoMT-based healthcare system using artificial intelligence. We have compared different data collection algorithms graphically based on their accuracy and error rate. Similarly, different energy efficiency algorithms are also graphically compared based on their energy consumption and packet loss percentage. We have analyzed our references used in this study, which are graphically represented based on their distribution of publication year and publication avenue.


Subject(s)
Internet of Things , Artificial Intelligence , Delivery of Health Care/methods , Pandemics , Reproducibility of Results
2.
Expert Opin Drug Deliv ; 18(4): 489-513, 2021 04.
Article in English | MEDLINE | ID: mdl-33225771

ABSTRACT

Introduction: Cancer has always been a menace for the society. Hepatocellular carcinoma (HCC) is one of the most lethal and 3rdlargest causes of deaths around the world.Area covered: The emergence of natural actives is considered as the greatest boon for fighting cancer. The natural actives take precedence over the traditional chemotherapeutic drugs in terms of their multi-target, multi-level and coordinated effects in the treatment of HCC. Literature reports have indicated the tremendous potential of bioactive natural products in inhibiting the HCC via molecular drug targeting, augmented bioavailability, and the ability for both passive or active targeting and stimulus-responsive drug release characteristics. This review provides a newer treatment approaches involved in the mechanism of action of different natural actives used for the HCC treatment via different molecular pathways. Besides, the promising advantage of natural bioactive-loaded nanocarriers in HCC treatment has also been also presented in this review. Expert opinion: The remarkable outcomes have been observed with therapeutic efficacy of the nanocarriers of natural actives in the treatment of HCC.Furthermore, it requires a thorough assessment of the safety and efficacy evaluation of the nanocarriers for the delivery of targeted natural active ingredients in HCC.].


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Nanoparticles , Carcinoma, Hepatocellular/drug therapy , Drug Carriers/therapeutic use , Drug Delivery Systems , Drug Liberation , Humans , Liver Neoplasms/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...